Sarcopenic Obesity: Time to Meet the Challenge
Open accessThe DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
The prevalence of overweight and obesity has reached epidemic proportions worldwide due to increasingly pervasive obesogenic lifestyle changes. Obesity poses unprecedented individual, social, and multidisciplinary medical challenges by increasing the risk for metabolic diseases, chronic organ failures, and cancer as well as complication rates in the presence of acute disease conditions. Whereas reducing excess adiposity remains the fundamental pathogenic treatment for obese individuals, complex metabolic and lifestyle abnormalities as well as weight reduction therapies per se may also compromise the ability to preserve muscle function and mass, especially when chronic disease co-exists with obesity. Emerging evidence indicates that low muscle mass and quality have a strong negative prognostic impact in obese individuals and may lead to frailty, disability, and increased morbidity and mortality. Awareness of the importance of skeletal muscle maintenance in obesity is however low among clinicians and scientists. The term ‘sarcopenic obesity' has been proposed to identify obesity with low skeletal muscle function and mass, but its utilization is largely limited to the aging patient population, and consensus on its definition and diagnostic criteria remains insufficient. Knowledge on prevalence of sarcopenic obesity in various clinical conditions and patient subgroups, on its clinical impacts in patient risk stratification, and on effective prevention and treatment strategies remain therefore dramatically inadequate. In particular, optimal dietary options and medical nutritional support strategies to preserve muscle mass in obese individuals remain largely undefined. The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) recognize and indicate obesity with altered body composition due to low skeletal muscle function and mass (sarcopenic obesity) as a scientific and clinical priority for researchers and clinicians. ESPEN and EASO therefore call for coordinated action aimed at reaching consensus on its definition, diagnostic criteria, and optimal treatment with particular regard to nutritional therapy. We are convinced that achievement of these goals has a strong potential to reduce the burden of morbidity and mortality in the rapidly increasing obese patient population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consensus statements have emphasized that SO should be understood as a disorder of body composition and function rather than as a simple coexistence of two diagnoses (1, 2).”
From Exercise-based interventions for sarcopenic obesity in middle-aged and older adults: an umbrella review of systematic reviews with pairwise meta-analyses and network meta-analyses (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“cytokines produced by infiltrating cells such as macrophages can cause muscular atrophy by inducing filament protein degradation and apoptosis (21).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [21]
In the citing paper
“Indeed, there are multiple biological effects of physical activity: promote insulin sensitivity, improve anabolic response to endogenous amino acids, activate skeletal muscle satellites cells and trigger the proliferation and differentiation of them, amplify irisin production, adjust hormonal milieu, increase mitochondrial biogenesis, ameliorate inflammation and reduce oxidative stress (162–164).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Self-citationThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“…: clustered metabolic de-rangements including systemic and muscle oxidative stress, in fl ammation and insulin resistance may occur in obesity [17 e 20] due to various causes that primarily include a) excess nutrient availability and tissue delivery, particularly saturated fat [28] and…”
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058 · cited 2×
“Reducing excess adiposity remains the fundamental pathogenetic treatment for obese individuals [15,16].”
McClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Self-citationGlobal burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 1×
“Indeed low or declining muscle mass is emerging as a negative prognostic factor associated with higher morbidity and mortality in obese patients with chronic diseases [67 e 69].”
Di Angelantonio, E., Bhupathiraju, S. N., Wormser, D., Gao, P., Kaptoge, S., de Gonzalez, A. B., Cairns, B. J., Huxley, R., Jackson, C. L., Joshy, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30175-1 · Cited by 2,821
ESPEN guidelines on definitions and terminology of clinical nutrition
Cederholm, T., Barazzoni, R., Austin, P., Ballmer, P., Biolo, G., Bischoff, S. C., Compher, C., Correia, I., Higashiguchi, T., Holst, M., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.09.004 · Cited by 2,560 · cited 2×
“…skeletal muscle function and mass as well as amino acid metabolism, with particular regard to cross-talk and interactions between skeletal muscle and adipose tissue also at stem cell level; additional important areas include mediators of positive effects of exercise, the role of gut…”
Self-citationBauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553 · cited 4×
“It should however be pointed out that despite gaps and limitations in knowledge, a large and growing body of evidence provides strong support for an association between protein and amino acid intake and skeletal muscle anabolism with maintenance of lean body mass [83,84].”
InfluentialSelf-citationBody-mass index and mortality among 1.46 million white adults
Berrington de Gonzalez, A., Hartge, P., Cerhan, J. R., Flint, A. J., Hannan, L., MacInnis, R. J., Moore, S. C., Tobias, G. S., Anton-Culver, H., Freeman, L. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000367 · Cited by 2,317
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Acute skeletal muscle wasting in critical illness
Puthucheary, Z. A., Rawal, J., McPhail, M., Connolly, B., Ratnayake, G., Chan, P., Hopkinson, N. S., Padhke, R., Dew, T., Sidhu, P. S., et al. (2013) · JAMA · doi:10.1001/jama.2013.278481 · Cited by 2,103 · cited 2×
“It may also concern patients recovering from critical illness or afterlong immobilization as in ICU [48 [83,84], adequate protein intake of 1 g/kg ideal body weight per day should be provided in healthy non-geriatric individuals.”
Cruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963 · cited 1×
“Multimodal therapeutic strategies should include physical activity and nutrition [79 e 82], that should in turn provide adequate high-quality protein intake [83,84] or protein-amino acid administration in patients in need of medical nutrition [83 e 85].”
Self-citationDeutz, N. E. P., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., Cederholm, T., Cruz-Jentoft, A., Krznariç, Z., Nair, K. S., et al. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.04.007 · Cited by 1,738
Self-citationThe pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484
Taylor, B. E., McClave, S. A., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001525 · Cited by 1,476
Bauer, U. E., Briss, P. A., Goodman, R. A., & Bowman, B. A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60648-6 · Cited by 1,394
Insulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258 · cited 3×
“…: muscle lipid accumulation commonly occurs [30] as a result of insuf fi cient adipose tissue expansion in the face of excess lipid availability [32]; convincing evidence has long demonstrated the close association of skeletal muscle lipid content with tissue and systemic insulin resistance [30,33].”
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
The economic burden of obesity worldwide: a systematic review of the direct costs of obesity
Withrow, D., & Alter, D. A. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00712.x · Cited by 1,083
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974 · cited 1×
“Liver steatosis, cirrhosis and cancer becomes a raising challenge for patients with long-standing obesity [14].”
Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study
Landi, F., Liperoti, R., Russo, A., Giovannini, S., Tosato, M., Capoluongo, E., Bernabei, R., & Onder, G. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.02.007 · Cited by 938 · cited 1×
“A profound negative clinical impact of low skeletal muscle function and mass is unequivocally emerging in many disease conditions and in aging [52,56,57].”
Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937 · cited 3×
“With this limitation in mind, obese individuals with low muscle mass or functional parameters had higher risk of developing frailty and disability, and therefore poor quality of life [65,66].”
Hypoxia and Adipose Tissue Function and Dysfunction in Obesity
Trayhurn, P. (2013) · Physiological Reviews · doi:10.1152/physrev.00017.2012 · Cited by 878 · cited 1×
“…as well as epicardial fat enlargement may also cause metabolic complications byenhancing ROS production and their negative metabolic impact [41,42]; 2) chronic and acute complications : obesity directly enhances the risk for, or may be associated with chronic organ failure syndromes and…”
Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults
Villareal, D. T., Aguirre, L., Gurney, A. B., Waters, D. L., Sinacore, D. R., Colombo, E., Armamento-Villareal, R., & Qualls, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616338 · Cited by 754 · cited 2×
“Needs : there is likely no ideal methodology to simultaneously achieve maximal precision, safety and routine applicability; since the latter is ultimately sought, surrogate markers may have to be accepted as reasonable compromises (e.g. as similarly applied for waist circumference relative to…”
A proposed clinical staging system for obesity
Sharma, A. M., & Kushner, R. F. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.2 · Cited by 687
Taekema, D. G., Gussekloo, J., Maier, A. B., Westendorp, R. G. J., & de Craen, A. J. M. (2010) · Age and Ageing · doi:10.1093/ageing/afq022 · Cited by 625 · cited 1×
“A profound negative clinical impact of low skeletal muscle function and mass is unequivocally emerging in many disease conditions and in aging [52,56,57].”
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589 · cited 2×
“The current de fi nitions of sarcopenic obesity combine sarcopenia, as de fi ned through variable criteria, to the presence of obesity either de fi ned as BMI > 30 kg/m 2 or by adiposity levels [61,71 e 73].”
Mitochondrial dysfunction and insulin resistance: an update
Montgomery, M. K., & Turner, N. (2015) · Endocrine Connections · doi:10.1530/ec-14-0092 · Cited by 527 · cited 1×
“…: clustered metabolic de-rangements including systemic and muscle oxidative stress, in fl ammation and insulin resistance may occur in obesity [17 e 20] due to various causes that primarily include a) excess nutrient availability and tissue delivery, particularly saturated fat [28] and glucose…”
Montano-Loza, A. J., Angulo, P., Meza-Junco, J., Prado, C. M. M., Sawyer, M. B., Beaumont, C., Esfandiari, N., Ma, M., & Baracos, V. E. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12039 · Cited by 512 · cited 1×
“Obese individuals with gastrointestinal cancers and low muscle mass accordingly had higher risk of dying than matched obese patients without muscle abnormalities [68].”
Changes in fat-free mass during significant weight loss: a systematic review
Chaston, T. B., Dixon, J. B., & O'Brien, P. E. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803483 · Cited by 493 · cited 1×
“Various complex inter-related mechanisms may contribute to these changes.”
Does nutrition play a role in the prevention and management of sarcopenia?
Robinson, S. M., Reginster, J. Y., Rizzoli, R., Shaw, S. C., Kanis, J. A., Bautmans, I., Bischoff-Ferrari, H., Bruyère, O., Cesari, M., Dawson-Hughes, B., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.08.016 · Cited by 491
Self-citationMijnarends, D. M., Meijers, J. M. M., Halfens, R. J. G., ter Borg, S., Luiking, Y. C., Verlaan, S., Schoberer, D., Cruz Jentoft, A. J., van Loon, L. J. C., & Schols, J. M. G. A. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.10.009 · Cited by 475 · cited 3×
“The current de fi nitions of sarcopenic obesity combine sarcopenia, as de fi ned through variable criteria, to the presence of obesity either de fi ned as BMI > 30 kg/m 2 or by adiposity levels [61,71 e 73].”
Rolland, Y., Lauwers-Cances, V., Cristini, C., van Kan, G. A., Janssen, I., Morley, J. E., & Vellas, B. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26950 · Cited by 465 · cited 1×
“…in obesity [17 e 20] due to various causes that primarily include a) excess nutrient availability and tissue delivery, particularly saturated fat [28] and glucose [29]; b) adipose tissue dysfunction upon activation of maladaptive responses in the presence of enhanced demand for lipid storage [30].”
Preserving Healthy Muscle during Weight Loss
Cava, E., Yeat, N. C., & Mittendorfer, B. (2017) · Advances in Nutrition · doi:10.3945/an.116.014506 · Cited by 452 · cited 3×
“…common and almost invariably lead to skeletal muscle catabolism at least in the initial rapid weight loss phase characterized by profoundly negative energy balance [50]; low-or very low calorie diets are associated with similar qualitative changes although to less pronounced degrees [23,51].”
Skeletal muscle atrophy during short-term disuse: Implications for age-related sarcopenia
Wall, B. T., Dirks, M. L., & van Loon, L. J. C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.07.003 · Cited by 400 · cited 1×
“…to both reduced strength and endurance [21]; physical inactivity that reduces muscle mass, mitochondrial biogenesis and function and tissue lipid oxidation, also leading to reduced strength and endurance and potentially enhancing tissue and systemic in fl ammation and oxidative stress [39,40,55].”
Weinheimer, E. M., Sands, L. P., & Campbell, W. W. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00298.x · Cited by 391
Batsis, J. A., Barre, L. K., Mackenzie, T. A., Pratt, S. I., Lopez‐Jimenez, F., & Bartels, S. J. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12260 · Cited by 330
Response of Skeletal Muscle Mitochondria to Hypoxia
Hoppeler, H., Vogt, M., Weibel, E. R., & Flück, M. (2003) · Experimental Physiology · doi:10.1113/eph8802513 · Cited by 328 · cited 1×
“…disease as well as epicardial fat enlargement may also cause metabolic complications byenhancing ROS production and their negative metabolic impact [41,42]; 2) chronic and acute complications : obesity directly enhances the risk for, or may be associated with chronic organ failure syndromes and…”
Dolan, R. D., Lim, J., McSorley, S. T., Horgan, P. G., & McMillan, D. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16955-5 · Cited by 300
Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals
Marcus, R. L., Addison, O., Dibble, L. E., Foreman, K. B., Morrell, G., & LaStayo, P. (2012) · Journal of Aging Research · doi:10.1155/2012/629637 · Cited by 296 · cited 1×
“Various complex inter-related mechanisms may contribute to these changes.”
Kalantar-Zadeh, K., Kopple, J. D., Kilpatrick, R. D., McAllister, C. J., Shinaberger, C. S., Gjertson, D. W., & Greenland, S. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.020 · Cited by 290 · cited 1×
“In chronic kidney disease patients, direction of changes in muscle mass was the major determinant of survival independently of direction of changes of total body weight [70].”
Tyrovolas, S., Koyanagi, A., Olaya, B., Ayuso‐Mateos, J. L., Miret, M., Chatterji, S., Tobiasz‐Adamczyk, B., Koskinen, S., Leonardi, M., & Haro, J. M. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12076 · Cited by 288 · cited 1×
“With this limitation in mind, obese individuals with low muscle mass or functional parameters had higher risk of developing frailty and disability, and therefore poor quality of life [65,66].”
Honda, H., Qureshi, A. R., Axelsson, J., Heimburger, O., Suliman, M. E., Barany, P., Stenvinkel, P., & Lindholm, B. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.633 · Cited by 282 · cited 1×
“…direct pro-oxidative and in fl ammatory activities [28] as well as accumulation of meta-bolically toxic lipid moieties such as diacylglycerol and ceram-ides [34]; recent evidences show that ectopic lipid deposition may also compromise muscle protein turnover [35]; 3) mitochondrial dysfunction…”
Current body composition measurement techniques
Lemos, T., & Gallagher, D. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000360 · Cited by 280 · cited 3×
“Functional measures also are heterogeneous and include hand-grip, knee extensor strength and various mobility measurements involving postural or walking tests [64].”
Physical activity in obesity and metabolic syndrome
Strasser, B. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06785.x · Cited by 279
Koster, A., Ding, J., Stenholm, S., Caserotti, P., Houston, D. K., Nicklas, B. J., You, T., Lee, J. S., Visser, M., Newman, A. B., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr070 · Cited by 274
Frühbeck, G., Toplak, H., Woodward, E., Yumuk, V., Maislos, M., Oppert, J.-M., & for the Executive Committee of the European Association for the Study of Obesity (2013) · Obesity Facts · doi:10.1159/000350627 · Cited by 264 · cited 1×
“Various complex inter-related mechanisms may contribute to these changes.”
Self-citationMathus-Vliegen, E. M. H., Basdevant, A., Finer, N., Hainer, V., Hauner, H., Micic, D., Maislos, M., Roman, G., Schutz, Y., Tsigos, C., et al. (2012) · Obesity Facts · doi:10.1159/000341193 · Cited by 261
Self-citationThe origin of intermuscular adipose tissue and its pathophysiological implications
Vettor, R., Milan, G., Franzin, C., Sanna, M., De Coppi, P., Rizzuto, R., & Federspil, G. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00229.2009 · Cited by 261 · cited 1×
“…stem cells that may undergo adipocyte differentiation are increasingly described in the context of complicated obesity and muscle fat accumulation [36 e 38], and their potential relevant role in limiting skeletal muscle mass maintenance has been proposed; 5) physical inactivity : low physical…”
Self-citationBeavers, K. M., Beavers, D. P., Houston, D. K., Harris, T. B., Hue, T. F., Koster, A., Newman, A. B., Simonsick, E. M., Studenski, S. A., Nicklas, B. J., et al. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.047860 · Cited by 259 · cited 1×
“The latter include muscle fat accumulation, that reduces muscle density and quality with lower contractile protein content per unit tissue [35,53,54]; mitochondrial dysfunction that may cause impaired ATP production and maximal oxygen consumption, leading to both reduced strength and endurance…”
Malnutrition and Cachexia in Heart Failure
Rahman, A., Jafry, S., Jeejeebhoy, K., Nagpal, A. D., Pisani, B., & Agarwala, R. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114566854 · Cited by 250
Lipid modulation of skeletal muscle mass and function
Lipina, C., & Hundal, H. S. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12144 · Cited by 247 · cited 1×
“…and in fl ammatory activities [28] as well as accumulation of meta-bolically toxic lipid moieties such as diacylglycerol and ceram-ides [34]; recent evidences show that ectopic lipid deposition may also compromise muscle protein turnover [35]; 3) mitochondrial dysfunction :…”
Bosy-Westphal, A., Jensen, B., Braun, W., Pourhassan, M., Gallagher, D., & Müller, M. J. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.27 · Cited by 231 · cited 2×
“A de fi nition of primary, age-associated sarcopenia and corresponding diagnostic criteria have been proposed [52], but relevant methodological issues and clinical thresholds for de fi ning criteria remain importantly under debate.”
Redox control of skeletal muscle atrophy.
Powers, S. K., Morton, A. B., Ahn, B., & Smuder, A. J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.021 · Cited by 207 · cited 1×
“These alterations are at least in part causally inter-related and have a strong muscle-catabolic potential [31]; they can also promote a typical “ anabolic resistance ” state in skeletal muscle, meaning that the response of muscle protein synthesis to nutrients is blunted [24 e 27]; 2) ectopic…”
Towards a multidisciplinary approach to understand and manage obesity and related diseases
Bischoff, S. C., Boirie, Y., Cederholm, T., Chourdakis, M., Cuerda, C., Delzenne, N. M., Deutz, N. E., Fouque, D., Genton, L., Gil, C., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.11.007 · Cited by 206 · cited 2×
“In addition, obese individuals are at higher risk for many chronic and acute diseases involving end-stage organ failures, cancer and infections [9 e 12].”
Self-citationBrocca, L., Cannavino, J., Coletto, L., Biolo, G., Sandri, M., Bottinelli, R., & Pellegrino, M. A. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.240267 · Cited by 194 · cited 1×
“…and oxidative stress [43 e 48] while impairing spontaneous physical activity, thereby synergistically enhancing muscle loss and dysfunction [49]; 3) surgical and medical treatment : bariatric procedures are becoming increasingly common and almost invariably lead to skeletal muscle…”
Obesity and Physical Frailty in Older Adults: A Scoping Review of Lifestyle Intervention Trials
Porter Starr, K. N., McDonald, S. R., & Bales, C. W. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.008 · Cited by 189
Tardif, N., Salles, J., Guillet, C., Tordjman, J., Reggio, S., Landrier, J., Giraudet, C., Patrac, V., Bertrand‐Michel, J., Migne, C., et al. (2014) · Aging Cell · doi:10.1111/acel.12263 · Cited by 186 · cited 1×
“Various complex inter-related mechanisms may contribute to these changes.”
Self-citationCrossland, H., Constantin‐Teodosiu, D., Gardiner, S. M., Constantin, D., & Greenhaff, P. L. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160150 · Cited by 184
Guillet, C., Delcourt, I., Rance, M., Giraudet, C., Walrand, S., Bedu, M., Duche, P., & Boirie, Y. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2216 · Cited by 176 · cited 3×
“It is however increasingly clear that profound skeletal muscle metabolism changes may occur in obesity and may lead to altered body composition with higher fat mass and substantial impairment of muscle mass and quality [24 e 27].”
InfluentialSelf-citationYasumoto, Y., Hashimoto, C., Nakao, R., Yamazaki, H., Hiroyama, H., Nemoto, T., Yamamoto, S., Sakurai, M., Oike, H., Wada, N., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.003 · Cited by 168 · cited 1×
“Risk for frailty and disability in obese individuals with low muscle function and mass has been importantly reported to be higher than that observed in non-obese counterparts with similar muscle alterations [65].”
von Ruesten, A., Steffen, A., Floegel, A., van der A, D. L., Masala, G., Tjønneland, A., Halkjaer, J., Palli, D., Wareham, N. J., Loos, R. J. F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027455 · Cited by 147 · cited 1×
“In many parts of the world, combined overweight (BMI > 25 kg/m 2 ) and obese individuals currently account for a majority of the population [3 e 6]; the proportion is substantially higher in middle-and elderly age groups [7,8].”
Dynamics of Change in Total and Regional Body Composition After Gastric Bypass in Obese Patients
Ciangura, C., Bouillot, J., Lloret‐Linares, C., Poitou, C., Veyrie, N., Basdevant, A., & Oppert, J. (2010) · Obesity · doi:10.1038/oby.2009.348 · Cited by 142 · cited 1×
“…common and almost invariably lead to skeletal muscle catabolism at least in the initial rapid weight loss phase characterized by profoundly negative energy balance [50]; low-or very low calorie diets are associated with similar qualitative changes although to less pronounced degrees [23,51].”
Biolo, G., Agostini, F., Simunic, B., Sturma, M., Torelli, L., Preiser, J. C., Deby-Dupont, G., Magni, P., Strollo, F., di Prampero, P., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.950 · Cited by 138 · cited 2×
“…to both reduced strength and endurance [21]; physical inactivity that reduces muscle mass, mitochondrial biogenesis and function and tissue lipid oxidation, also leading to reduced strength and endurance and potentially enhancing tissue and systemic in fl ammation and oxidative stress [39,40,55].”
Fogelholm, M., Malmberg, J. J., Suni, J. H., Santtila, M., Kyröläinen, H., & Mäntysaari, M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803243 · Cited by 137 · cited 1×
“…turnover [35]; 3) mitochondrial dysfunction : mitochondrial changes are not invariably observed in obese skeletal muscle until relatively late stages [21,22]; their onset may however exacerbate oxidative stress and related metabolic cascades leading to insulin resistance and catabolism [21,22].”
Collins, K. H., Paul, H. A., Hart, D. A., Reimer, R. A., Smith, I. C., Rios, J. L., Seerattan, R. A., & Herzog, W. (2016) · Scientific Reports · doi:10.1038/srep37278 · Cited by 125
Cuthbertson, D. J., Steele, T., Wilding, J. P., Halford, J. C., Harrold, J. A., Hamer, M., & Karpe, F. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.4 · Cited by 125 · cited 1×
“…: muscle lipid accumulation commonly occurs [30] as a result of insuf fi cient adipose tissue expansion in the face of excess lipid availability [32]; convincing evidence has long demonstrated the close association of skeletal muscle lipid content with tissue and systemic insulin resistance…”
Barazzoni, R., Zanetti, M., Cappellari, G. G., Semolic, A., Boschelle, M., Codarin, E., Pirulli, A., Cattin, L., & Guarnieri, G. (2011) · Diabetologia · doi:10.1007/s00125-011-2396-x · Cited by 120
Self-citationSchollenberger, A. E., Karschin, J., Meile, T., Küper, M. A., Königsrainer, A., & Bischoff, S. C. (2016) · Nutrition · doi:10.1016/j.nut.2015.08.005 · Cited by 118 · cited 1×
“…routinely recommended particularly in patients with low muscle function and mass in need to undergo weight-losing treatment, or in those at higher risk of developing such changes during weight loss; oral protein supplements should be considered when suf fi cient dietary intake is not possible [88].”
Self-citationSmeuninx, B., Mckendry, J., Wilson, D., Martin, U., & Breen, L. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00869 · Cited by 118 · cited 3×
“…BMI and lean body mass has been reported in general population studies [23] and moderate increments in skeletal muscle mass may occur in obesity as a consequence of higher postural and ambulatory muscle work as well as potential direct anabolic effects of higher dietary intake of calorie-proteins.”
Barazzoni, R., Deutz, N. E. P., Biolo, G., Bischoff, S., Boirie, Y., Cederholm, T., Cuerda, C., Delzenne, N., Leon Sanz, M., Ljungqvist, O., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.09.010 · Cited by 112 · cited 2×
“…abnormalities [17 e 22] as well as weight-reduction therapies per se [23] may however also compromise the ability to preserve muscle function and mass. Skeletal muscle changes are not uniformly observed in obese individuals and heterogeneous phenotypes may contribute to their underestimation.”
Self-citationBeals, J. W., Sukiennik, R. A., Nallabelli, J., Emmons, R. S., van Vliet, S., Young, J. R., Ulanov, A. V., Li, Z., Paluska, S. A., De Lisio, M., et al. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.130385 · Cited by 99
Evolving concepts on adjusting human resting energy expenditure measurements for body size
Heymsfield, S. B., Thomas, D., Bosy‐Westphal, A., Shen, W., Peterson, C. M., & Müller, M. J. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01019.x · Cited by 98 · cited 1×
“- Patient groups and clinical settings: Limitations : the concept of sarcopenia and sarcopenic obesity have been primarily de fi ned and applied in geriatric populations [8,52,65].”
Murton, A. J., Marimuthu, K., Mallinson, J. E., Selby, A. L., Smith, K., Rennie, M. J., & Greenhaff, P. L. (2015) · Diabetes · doi:10.2337/db15-0021 · Cited by 97
Sarcopenic obesity: satellite cells in the aging muscle
Thornell, L.-E. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283412260 · Cited by 86 · cited 1×
“…cells that may undergo adipocyte differentiation are increasingly described in the context of complicated obesity and muscle fat accumulation [36 e 38], and their potential relevant role in limiting skeletal muscle mass maintenance has been proposed; 5) physical inactivity : low physical activity…”
Mingrone, G., Rosa, G. D., Rocco, P. D., Manco, M., Capristo, E., Castagneto, M., Vettor, R., Gasbarrini, G. B., & Greco, A. V. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802053 · Cited by 82 · cited 1×
“…: muscle lipid accumulation commonly occurs [30] as a result of insuf fi cient adipose tissue expansion in the face of excess lipid availability [32]; convincing evidence has long demonstrated the close association of skeletal muscle lipid content with tissue and systemic insulin resistance [30,33].”
Self-citationDeger, S. M., Hung, A. M., Gamboa, J. L., Siew, E. D., Ellis, C. D., Booker, C., Sha, F., Li, H., Bian, A., Stewart, T. G., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95185 · Cited by 77
Gurunathan, U., Ramsay, S., Mitric, G., Way, M., Wockner, L. F., & Myles, P. S. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3494-y · Cited by 75 · cited 1×
“For example, overweight and obese patients carry at least 70% higher risk for coronary disease and 20% e 50% higher risk of developing wound infections after colorectal surgery compared to normal weight patients, respectively [13].”
ICU-acquired weakness: what is preventing its rehabilitation in critically ill patients?
Lee, C. M., & Fan, E. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-115 · Cited by 73 · cited 1×
“Physical support-rehabilitation should fi nally be implemented whenever possible according to patient status [89].”
Kang, C., & Ji, L. L. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01354.2012 · Cited by 72 · cited 1×
“Various complex inter-related mechanisms may contribute to these changes.”
Increased adipogenic conversion of muscle satellite cells in obese Zucker rats
Scarda, A., Franzin, C., Milan, G., Sanna, M., Prà, C. D., Pagano, C., Boldrin, L., Piccoli, M., Trevellin, E., Granzotto, M., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.47 · Cited by 69
Self-citationBeavers, K. M., Hsu, F.-C., Houston, D. K., Beavers, D. P., Harris, T. B., Hue, T. F., Kim, L. J., Koster, A., Penninx, B. W., Simonsick, E. M., et al. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls213 · Cited by 47
Dahlmans, D., Houzelle, A., Schrauwen, P., & Hoeks, J. (2016) · Clinical Science · doi:10.1042/cs20150780 · Cited by 44 · cited 3×
“…or overt type 2 diabetes and hyperglycemia are associated with enhanced oxidative stress, pro-in fl ammatory changes and mitochondrial dysfunction [21,29] that commonly cause catabolic abnormalities and may independently further muscle alterations; altered tissue perfusion in the presence or…”
Designing, testing, and implementing a sustainable nurse home visiting program: right@home
Goldfeld, S. R., Price, A. M. H., & Kemp, L. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13688 · Cited by 41
Bosy-Westphal, A., & Müller, M. J. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000201 · Cited by 25 · cited 1×
“Bioelectrical impedence analysis has been considered and proposed as a potential acceptable compro-miseintermsof invasiveness,accuracyandapplicability, inthe absence of confounding fl uid balance abnormalities [76,77].”
Inflammation and Adipose Tissue in Uremia
Barazzoni, R., Biolo, G., Zanetti, M., Bernardi, A., & Guarnieri, G. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.005 · Cited by 22 · cited 1×
“Various complex inter-related mechanisms may contribute to these changes.”
Self-citationZafrir, B., Salman, N., & Amir, O. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.030 · Cited by 15
Cited by
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
Self-citationDefinition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
Self-citationDonini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.024 · Cited by 326
“In recent years, the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) have issued joint statements calling for further collaborative efforts aimed at overcoming existing hurdles towards clinical applicability of the sarcopenic obesity concept […”
BackgroundSelf-citationSarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
Wei, S., Nguyen, T. T., Zhang, Y., Ryu, D., & Gariani, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185221 · Cited by 291
Obesity and ageing: Two sides of the same coin
Tam, B. T., Morais, J. A., & Santosa, S. (2020) · Obesity Reviews · doi:10.1111/obr.12991 · Cited by 253
“With obesity, deleterious alterations in skeletal muscle structure and metabolism may result in declines in muscle mass and function.(154)”
Background
Metadata
- Authors
- Barazzoni, R., Bischoff, S., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R.
- Affiliations
- University of Trieste (IT)
- University of Hohenheim (DE)
- University of Padua (IT)
- Uppsala University (SE)
- Tel Aviv University (IL)
- Medical University of Graz (AT)
- Istanbul University-Cerrahpaşa (TR)
- ORCID
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 11
- Issue
- 4
- Pages
- 294-305
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- PMC
- PMC6189532
- OpenAlex
- W2883874811
- Cited by
- 244
- References
- 92
- Citations by year
- 2026: 33 · 2025: 26 · 2024: 31 · 2023: 46 · 2022: 39 · 2021: 37 · 2020: 18 · 2019: 11 · 2018: 3
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Obesity Facts (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by-nc-nd)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenic obesity, obesity, skeletal muscle mass, muscle function, frailty, body composition, diagnostic criteria, nutritional therapy, weight loss, chronic comorbidities
- MeSH terms
- Body Composition, Diet, Humans, Life Style, Obesity, Risk Factors, Prevalence, Muscle, Skeletal, Adiposity, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.